Nordic Nanovector ASA - Contemplated private placement of new shares
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Nordic Nanovector ASA - Contemplated private placement of new shares Oslo, 19 January 2022. Nordic Nanovector ASA (OSE: NANOV) (“Nordic Nanovector” or the “Company”), a clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and